BioSpace News Archive

Apellis Pharmaceuticals, Inc. announced that the company approved the grant of an equity award to a new employee with a grant date of January 13, 2020, as an equity inducement award outside of the company’s 2017 Stock Incentive Plan and material to the employee’s acceptance of employment with the company.

RCP is HARMAN’s latest offering for healthcare which will further enable providers to digitize their services and processes to maintain pace with the market and patient demands.

John Madigan, senior vice president of public policy for the American Foundation for Suicide Prevention (AFSP), the nation’s largest suicide prevention organization, today released this statement:

Additional details were added to the Rybelsus® (semaglutide) tablets 7 mg or 14 mg Prescribing Information about the primary analysis for PIONEER 6.

DisposeRx, Inc. has received its first patent from the US Patent and Trademark Office.

Novelion Therapeutics Inc. announced that the implementation of the Company’s voluntary liquidation commenced at 5:00 p.m. Pacific Time, January 16, 2020.

Technavio has announced its latest market research report titled global vascular embolization devices market 2020-2024.

Exactus, Inc. (OTCQB:EXDI) (the “Company”), a hemp farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that it has appointed Daniel Alberttis to its Board of Directors.

HEXO Corp. (“HEXO” or the “Company”) (TSX:HEXO) is pleased to announce the results of its annual general meeting of shareholders held on January 15, 2020.

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, announces that it has entered into an agreement with the University Health Network (UHN) to perform a clinical experience program to enable it and three independent neurorehabilitation clinics in Canada to evaluate the Company’s Portable Neuromodulation Stimulator (PoNS™) device,